NCT03648918 Genetics Of Autoimmunity In Type I Diabetes
| NCT ID | NCT03648918 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical College of Wisconsin |
| Condition | Type1diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2001-08 |
| Primary Completion | 2050-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2001-08 with a primary completion date of 2050-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to gain more information about the step-by-step process that causes someone to develop type 1 diabetes. Scientists think that a person's own immune system, directed by genetic and environmental factors play a major role in its development. Participation involves a blood draw, a brief medical history questionnaire and measurements of height and weight. Some participants will be asked to return for annual follow-up visits for 10 years.
Eligibility Criteria
Inclusion Criteria (Families): * Families where at least one first-degree family member has type 1 diabetes * The diabetic proband in the family was diagnosed before the age of 39 * Family members must be at least 2 years old to participate Exclusion Criteria (Families): * Families with no history of type 1 diabetes * Families with a history of diabetes that is not type 1 (LADA, MODY, type 2 etc.) Inclusion Criteria (Controls): * No family history of type 1 diabetes or other autoimmune conditions * Age 2 or older Exclusion Criteria (Controls): * Personal or family history of autoimmune disease
Contact & Investigator
Martin Hessner, PhD
PRINCIPAL INVESTIGATOR
Medical College of Wisconsin
Frequently Asked Questions
Who can join the NCT03648918 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, studying Type1diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03648918 currently recruiting?
Yes, NCT03648918 is actively recruiting participants. Contact the research team at t1dinfo@mcw.edu for enrollment information.
Where is the NCT03648918 trial being conducted?
This trial is being conducted at Milwaukee, United States.
Who is sponsoring the NCT03648918 clinical trial?
NCT03648918 is sponsored by Medical College of Wisconsin. The principal investigator is Martin Hessner, PhD at Medical College of Wisconsin. The trial plans to enroll 4,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.